John Overdeck’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
John Overdeck's TEVA Position: Q3 2026 in Review
John Overdeck reduced its Teva Pharmaceutical Industries (TEVA) stake by 16% in Q3 2026, selling an estimated $1.36M and leaving 193,287 shares worth $7.65M. The position accounts for 0.01% of the portfolio, ranked #1775.
John Overdeck first reported a position in TEVA in Q2 2013 and has held it in 50 quarters since. The position peaked at $142M in Q4 2016. 598 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- John Overdeck held 193,287 shares of Teva Pharmaceutical Industries worth $7.65M as of Q3 2026.
- John Overdeck sold 38,000 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $1.36M.
- Teva Pharmaceutical Industries made up 0.01% of John Overdeck's portfolio in Q3 2026, its #1775 holding.
- John Overdeck first reported a position in Teva Pharmaceutical Industries in Q2 2013 and has held it in 50 quarters since.
- John Overdeck's Teva Pharmaceutical Industries position peaked at $142M in Q4 2016.
- 598 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.